Publikationen von 0000-0003-3254-9121
(ORCID: 0000-0003-3254-9121)

Sousa, Luis , Pankonien, Ines , Clarke, Luka A. , Silva, Iris , Kunzelmann, Karl und Amaral, Margarida D. (2020) KLF4 Acts as a wt-CFTR Suppressor through an AKT-Mediated Pathway. Cells 9 (7), S. 1607. Volltext nicht vorhanden.

Silva, Iris A.L., Doušová, Tereza, Ramalho, Sofia, Centeio, Raquel, Clarke, Luka A. , Railean, Violeta, Botelho, Hugo M., Holubová, Andrea, Valášková, Iveta, Yeh, Jiunn-Tyng, Hwang, Tzyh-Chang, Farinha, Carlos M., Kunzelmann, Karl und Amaral, Margarida D. (2020) Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>G. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866 (11), S. 165905. Volltext nicht vorhanden.

Almaça, Joana , Faria, Diana , Sousa, Marisa, Uliyakina, Inna , Conrad, Christian, Sirianant, Lalida, Clarke, Luka A. , Martins, José Paulo , Santos, Miguel , Heriché, Jean-Karim , Huber, Wolfgang , Schreiber, Rainer, Pepperkok, Rainer , Kunzelmann, Karl und Amaral, Margarida D. (2013) High-Content siRNA Screen Reveals Global ENaC Regulators and Potential Cystic Fibrosis Therapy Targets. Cell 154 (6), S. 1390-1400. Volltext nicht vorhanden.

Martins, Joana Raquel , Kongsuphol, Patthara, Sammels, Eva, Dahimène, Shehrazade, AlDehni, Fadi, Clarke, Luka Alexander , Schreiber, Rainer, de Smedt, Humbert, Amaral, Margarida D. und Kunzelmann, Karl (2011) F508del-CFTR increases intracellular Ca2+ signaling that causes enhanced calcium-dependent Cl− conductance in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812 (11), S. 1385-1392. Volltext nicht vorhanden.